Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations

Gynecologic Oncology

Volumn 121, Issue 2, 2011, Pages 358-363

  Lacour, Robin A ^a   Westin, Shannon N ^a   Meyer, Larissa A ^a   Wingo, Shana N ^b   Schorge, John O ^b   Brooks, Rebecca ^c   Mutch, David ^c   Molina, Ashley ^d   Sutphen, Rebecca ^d   Barnes, MacK ^e   Elder, Jeffrey ^e   Teoh, Deanna ^f   Powell, C Bethan ^f   Choubey, Veena ^g   Blank, Stephanie ^g   MacDonald, Heather R ^h   Brady, Mark F ⁱ   Urbauer, Diana L ^a   Bodurka, Diane ^a   Gershenson, David M ^a   Lu, Karen H ^a   more..

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NEW YORK UNIVERSITY   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ Buffalo Niagara Enterprise   (United States)

Author keywords

BRCA; Non Askenazi Jewish; Ovarian cancer; Survival; Survival bias

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE TEST; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FISHER EXACT TEST; GENE MUTATION; GENETIC SCREENING; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL;

CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE-FREE SURVIVAL; FALLOPIAN TUBE NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; JEWS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 79955476362     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.12.354     Document Type: Article

References (23)

1. R.F. Ozols, S.C. Rubin, G.M. Thomas, and S.J. Robboy Epithelial ovarian cancer W.J. Hoskins, R.C. Young, M. Markman, C.A. Perez, R.R. Barakat, M.E. Randall, Principles and practice of gynecologic oncology 4th ed 2005 Lippincott Williams & Wilkins Philadelphia 895 987
2. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer Statistics, 2010 CA Cancer J Clin 2010 [epub ahead of print]
3. Centers for Disease Control. Ovarian Cancer Control Initiative from the National Center for Chronic Disease Prevention and Health Promotion; 2010 [updated 2010 May 26; cited 2010 Aug 4]. Available from: http://www.cdc.gov/ cancer/ovarian/index.htm
4. J. Boyd Specific keynote: hereditary ovarian cancer: what we know Gynecol Oncol 88 2003 S8 S10
5. D.F. Easton, D. Ford, and D.T. Bishop Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium Am J Hum Genet 56 1995 265 271
6. D.F. Easton, L. Steele, P. Fields, W. Ormiston, D. Averill, and P.A. Daly Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13 Am J Hum Genet 61 1997 120 128 (Pubitemid 27323331)
7. J.P. Struewing, P. Hartge, S. Wacholder, S.M. Baker, M. Berlin, and M. McAdams The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med. 336 1997 1401 1408 (Pubitemid 27208598)
8. D. Ford, D.F. Easton, M. Stratton, S. Narod, D. Goldgar, and P. Devilee Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families Am J Hum Genet 62 1998 676 689 (Pubitemid 28164626)
9. R. Moslehi, W. Chu, B. Karlan, D. Fishman, H. Risch, and A. Fields BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer Am J Hum Genet 66 2000 1259 1272 (Pubitemid 30468783)
10. M.C. King, J.H. Marks, and J.B. Mandell The New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 2003 643 646 (Pubitemid 37310920)
11. National Cancer Institute. Genetics of Breast and Ovarian Cancer; 2010 [updated 2010 July 22; cited 2010 Aug 4]. Available from: http://www.cancer.gov/ cancertopics/pdq/genetics/breast-and-ovarian
12. J. Boyd, Y. Sonoda, M.G. Federici, F. Bogomolniy, E. Rhei, and D.L. Maresco Clinicopathologic features of BRCA-linked and sporadic ovarian cancer JAMA. 283 2000 2260 2265 (Pubitemid 30246777)
13. Y. Bendavid, A. Chetrit, G. Hirsh-Yechezkel, E. Friedman, B.D. Beck, and U. Beller Effect of BRCA mutations n length of survival in epithelial ovarian tumors J Clin Oncol 20 2002 463 466 (Pubitemid 34072530)
14. A. Chetrit, G. Hirsh-Yechezkel, Y. Ben-David, F. Lubin, E. Friedman, and S. Sadetzki Effects of BRCA 1/2 mutations on long- term survival of patients with invasive ovarian cancer: The National Israeli Study of Ovarian Cancer J Clin Oncol 26 2008 20 25
15. P.D. Pharoah, D.F. Easton, D.L. Stockton, S. Gayther, and B.A. Ponder Survival in familial, BRCA1-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group Cancer Res. 59 1999 868 871
16. R.P. Zweemer, R.H.M. Verheijen, J.W. Coebergh, I.J. Jacobs, P.J. van Diest, and J.J. Gille Survival analysis in familial ovarian cancer, a case control study Eur J Obstet Gynecol Reprod Biol. 98 2001 219 223 (Pubitemid 33713896)
17. D.S.P. Tan, C. Rothermundt, K. Thomas, E. Bancroft, R. Eeles, and S. Shanley "BRCAness" Syndrome in Ovarian Cancer: a control- control study describing the clinical features and outcomes of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations J Clin Oncol. 26 2008 5530 5536
18. O.T. Johannsson, J. Ranstam, A. Borg, and H. Olsson Survival of BRCA1 breast and ovarian cancer patients: a population-based study from Southern Sweden J Clin Oncol. 16 1998 397 404 (Pubitemid 28135579)
19. M.A. Bookman, M.F. Brady, W.P. McGuire, P.G. Harper, D.S. Alberts, and M. Friedlander Evaluation of new platinum- based treatment regimens in advanced- stage ovarian cancer: A phase III trial of the Gynecologic Cancer InterGroup J Clin Oncol. 27 2009 1419 1425
20. S.C. Rubin, I. Benjamin, K. Behbakht, H. Takahashi, M.A. Morgan, and V.A. LiVolsi Clinical and pathologic features of ovarian cancer in women with germline mutations of BRCA1 N Engl J Med. 335 1996 1413 1416 (Pubitemid 26382501)
21. I. Cass, R.L. Baldwin, T. Varkey, R. Moslehi, S.A. Narod, and B.Y. Karlan Improved survival in women with BRCA-associated ovarian cancer Cancer. 97 2003 2187 2195 (Pubitemid 36444059)
22. T.S. Frank, A.M. Deffenbaugh, J.E. Reid, M. Hulick, B.E. Ward, and B. Lingenfelter Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10, 000 individuals J Clin Oncol. 20 2002 1480 1490 (Pubitemid 34260526)
23. T. Pal, J. Permuth-Wey, J.A. Betts, J.P. Krischer, J. Fiorica, and H. Arango BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases Cancer 104 2005 2807 2816 (Pubitemid 41798292)